Michael King - Nov 30, 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Michael G. King, Jr.
Stock symbol
SABS
Transactions as of
Nov 30, 2023
Transactions value $
$4,500
Form type
4
Date filed
11/30/2023, 05:00 PM
Previous filing
Nov 3, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Purchase $4.5K +5K $0.90 5K Nov 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 5,000 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.